SMITH V.

Therapies targeting underlying vascular disease in SSc have been successfully designed to improve the symptoms of Raynaud phenomenon and to reduce ischemic injury to involved organs, and NVC patterns have been found to improve following targeted therapy.

Nailfold capillaroscopy represents in SSc an outcome measure for clinical trials on the peripheral vasculopathy.